ABIGAIL PLONK: Open Payments
NPI 1265456420 · WINSTON SALEM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,165 in 55 payments from 17 companies in 2025. Trend: 2023 $1,434 · 2024 $1,308 · 2025 $1,165
Food & beverage: $1,093Education: $72
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $281 |
| GENZYME CORPORATION | 7 | $192 |
| Amgen Inc. | 7 | $138 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $103 |
| UCB, Inc. | 5 | $98 |
| Galderma Laboratories, L.P. | 3 | $52 |
| Incyte Corporation | 2 | $49 |
| Janssen Biotech, Inc. | 3 | $48 |
| Regeneron Healthcare Solutions, Inc. | 2 | $45 |
| Lilly USA, LLC | 2 | $32 |
Products named: DUPIXENT, RINVOQ, Otezla, SKYRIZI, Bimzelx, NEMLUVIO, OPZELURA, TREMFYA.
Industry payments across NC — which companies pay providers there.
